86.52
0.38 (0.44%)
| Penutupan Terdahulu | 86.14 |
| Buka | 85.00 |
| Jumlah Dagangan | 1,195,182 |
| Purata Dagangan (3B) | 1,685,398 |
| Modal Pasaran | 42,794,176,512 |
| Harga / Pendapatan (P/E TTM) | 38.45 |
| Harga / Pendapatan (P/E Ke hadapan) | 28.25 |
| Harga / Jualan (P/S) | 4.34 |
| Harga / Buku (P/B) | 1.94 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 19 Aug 2025 |
| Hasil Dividen (DY TTM) | 0.35% |
| Margin Keuntungan | 11.28% |
| Margin Operasi (TTM) | 13.30% |
| EPS Cair (TTM) | 2.25 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 0.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 41.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 23.63% |
| Nisbah Semasa (MRQ) | 2.70 |
| Aliran Tunai Operasi (OCF TTM) | 2.12 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.18 B |
| Pulangan Atas Aset (ROA TTM) | 2.74% |
| Pulangan Atas Ekuiti (ROE TTM) | 5.23% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menurun | Menurun |
| Medical Instruments & Supplies (Global) | Menurun | Menurun | |
| Stok | Alcon Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.25 |
|
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Large Core |
| % Dimiliki oleh Orang Dalam | 0.13% |
| % Dimiliki oleh Institusi | 68.26% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 107.00 (Needham, 23.67%) | Beli |
| Median | 93.00 (7.49%) | |
| Rendah | 84.00 (Morgan Stanley, -2.91%) | Pegang |
| Purata | 94.67 (9.42%) | |
| Jumlah | 1 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 85.52 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Needham | 13 Aug 2025 | 107.00 (23.67%) | Beli | 86.48 |
| Wells Fargo | 06 Aug 2025 | 93.00 (7.49%) | Pegang | 84.12 |
| Morgan Stanley | 15 Jul 2025 | 84.00 (-2.91%) | Pegang | 85.95 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Aug 2025 | Pengumuman | Alcon Agrees to Acquire STAAR Surgical |
| 08 Jul 2025 | Pengumuman | Alcon’s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval |
| 07 Jul 2025 | Pengumuman | Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD) |
| 26 Jun 2025 | Pengumuman | Alcon Canada Earns Global Recognition as a Top Employer |
| 20 Jun 2025 | Pengumuman | Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL |
| 28 May 2025 | Pengumuman | Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease |
| Hasil Dividen (DY TTM) | 0.35% |
| Purata Hasil Dividen 4T | 0.26% |
| Nisbah Pembayaran | 11.81% |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 14 May 2024 | 08 Apr 2024 | 16 May 2024 | 0.2644 Tunai |
| 10 May 2023 | 30 Mar 2023 | 12 May 2023 | 0.2356 Tunai |
| 29 Apr 2022 | 24 Mar 2022 | 05 May 2022 | 0.2083 Tunai |
| 04 May 2021 | 24 Mar 2021 | 06 May 2021 | 0.0909 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2024 | 0.264 | 1 | 0.31 |
| 2023 | 0.236 | 1 | 0.30 |
| 2022 | 0.208 | 1 | 0.30 |
| 2021 | 0.091 | 1 | 0.10 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |